Biblio
Export 1397 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is P [Clear All Filters]
“Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 809-817, 2017.
, “Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS).”, J Alzheimers Dis, vol. 57, no. 1, pp. 195-204, 2017.
, “Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.”, J Alzheimers Dis, vol. 59, no. 2, pp. 695-705, 2017.
, “Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.”, J Alzheimers Dis, vol. 59, no. 2, pp. 695-705, 2017.
, “Attitudes toward Potential Participant Registries.”, J Alzheimers Dis, vol. 56, no. 3, pp. 939-946, 2017.
, “Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 305-315, 2017.
, “Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 60, no. 1, pp. 263-272, 2017.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “Benefits of Occupational Therapy in Dementia Patients: Findings from a Real-World Observational Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 509-517, 2017.
, “Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 69-78, 2017.
, “Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?”, J Alzheimers Dis, vol. 58, no. 2, pp. 323-335, 2017.
, “Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?”, J Alzheimers Dis, vol. 58, no. 2, pp. 323-335, 2017.
, “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
, “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
, “Body Mass Index, Height, and Socioeconomic Position in Adolescence, Their Trajectories into Adulthood, and Cognitive Function in Midlife.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1207-1221, 2017.
, “The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1639-1657, 2017.
, “Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 2, pp. 663-677, 2017.
, “CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1137-1149, 2017.
, “Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 57, no. 2, pp. 557-573, 2017.
, “Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 1, pp. 369-385, 2017.
, “Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 183-200, 2017.
, “Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 183-200, 2017.
, “Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 813-822, 2017.
, “Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 939-950, 2017.
,